Literature DB >> 22555459

Role of Gadd45a in Wip1-dependent regulation of intestinal tumorigenesis.

O N Demidov1, Y Zhu, C Kek, A R Goloudina, N Motoyama, D V Bulavin.   

Abstract

Conversion of intestinal stem cells into tumor-initiating cells is an early step in Apc(Min)-induced polyposis. Wild-type p53-induced phosphatase 1 (Wip1)-dependent activation of a DNA damage response and p53 has a permanent role in suppression of stem cell conversion, and deletion of Wip1 lowers the tumor burden in Apc(Min) mice. Here we show that cyclin-dependent kinase inhibitor 2a, checkpoint kinase 2, and growth arrest and DNA damage gene 45a (Gadd45a) exert critical functions in the tumor-resistant phenotype of Wip1-deficient mice. We further identified Gadd45a as a haploinsufficient gene in the regulation of Wip1-dependent tumor resistance in mice. Gadd45a appears to function through its ability to activate the Jnk-dependent signaling pathway that in turn is a necessary mediator of the proapoptotic functions of p53 that respond to activation of the β-catenin signaling pathway. We propose that silencing of Gadd45a is sufficient to override p53 activation in the presence of active β-catenin under conditions of an enhanced DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555459      PMCID: PMC3469057          DOI: 10.1038/cdd.2012.57

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  39 in total

1.  Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.

Authors:  Jing Li; Ying Yang; Yue Peng; Richard J Austin; Winfried G van Eyndhoven; Ken C Q Nguyen; Tim Gabriele; Mila E McCurrach; Jeffrey R Marks; Timothy Hoey; Scott W Lowe; Scott Powers
Journal:  Nat Genet       Date:  2002-05-20       Impact factor: 38.330

Review 2.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

3.  Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription.

Authors:  Hiroyuki Takai; Kazuhito Naka; Yuki Okada; Miho Watanabe; Naoki Harada; Shin'ichi Saito; Carl W Anderson; Ettore Appella; Makoto Nakanishi; Hiroshi Suzuki; Kazuo Nagashima; Hirofumi Sawa; Kyoji Ikeda; Noboru Motoyama
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

4.  Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration.

Authors:  Owen J Sansom; Karen R Reed; Anthony J Hayes; Heather Ireland; Hannah Brinkmann; Ian P Newton; Eduard Batlle; Patricia Simon-Assmann; Hans Clevers; Inke S Nathke; Alan R Clarke; Douglas J Winton
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

Review 5.  Lessons from hereditary colorectal cancer.

Authors:  K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

6.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.

Authors:  Dmitry V Bulavin; Oleg N Demidov; Shin'ichi Saito; Paivikki Kauraniemi; Crissy Phillips; Sally A Amundson; Concetta Ambrosino; Guido Sauter; Angel R Nebreda; Carl W Anderson; Anne Kallioniemi; Albert J Fornace; Ettore Appella
Journal:  Nat Genet       Date:  2002-05-20       Impact factor: 38.330

7.  Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.

Authors:  Dmitry V Bulavin; Oleg Kovalsky; M Christine Hollander; Albert J Fornace
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53.

Authors:  Jeffrey Hildesheim; Dmitry V Bulavin; Miriam R Anver; W Gregory Alvord; M Christine Hollander; Lilit Vardanian; Albert J Fornace
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

9.  Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.

Authors:  Lin Yang; Han C Dan; Mei Sun; Qiyuan Liu; Xia-meng Sun; Richard I Feldman; Andrew D Hamilton; Mark Polokoff; Santo V Nicosia; Meenhard Herlyn; Said M Sebti; Jin Q Cheng
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

10.  Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.

Authors:  Dmitry V Bulavin; Crissy Phillips; Bonnie Nannenga; Oleg Timofeev; Larry A Donehower; Carl W Anderson; Ettore Appella; Albert J Fornace
Journal:  Nat Genet       Date:  2004-02-29       Impact factor: 38.330

View more
  6 in total

1.  Wip1 abrogation decreases intestinal tumor frequency in APC(Min/+) mice irrespective of radiation quality.

Authors:  Shubhankar Suman; Bo-Hyun Moon; Hemang Thakor; Albert J Fornace; Kamal Datta
Journal:  Radiat Res       Date:  2014-08-12       Impact factor: 2.841

2.  Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.

Authors:  Giuseppe S Sica; Cristina Fiorani; Carmine Stolfi; Giovanni Monteleone; Eleonora Candi; Ivano Amelio; Valeria Catani; Simone Sibio; Andrea Divizia; Giorgia Tema; Edoardo Iaculli; Achille L Gaspari
Journal:  Oncotarget       Date:  2015-05-30

3.  Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.

Authors:  V Clausse; A R Goloudina; B Uyanik; E Y Kochetkova; S Richaud; O A Fedorova; A Hammann; M Bardou; N A Barlev; C Garrido; O N Demidov
Journal:  Cell Death Dis       Date:  2016-04-14       Impact factor: 8.469

4.  Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.

Authors:  Sona Pechackova; Kamila Burdova; Jan Benada; Petra Kleiblova; Gabriela Jenikova; Libor Macurek
Journal:  Oncotarget       Date:  2016-03-22

Review 5.  Wip1 phosphatase: between p53 and MAPK kinases pathways.

Authors:  Anastasia R Goloudina; Elena Y Kochetkova; Tatyana V Pospelova; Oleg N Demidov
Journal:  Oncotarget       Date:  2016-05-24

6.  Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon.

Authors:  Monika Burocziova; Kamila Burdova; Andra S Martinikova; Petr Kasparek; Petra Kleiblova; Stine A Danielsen; Marianna Borecka; Gabriela Jenikova; Lucie Janečková; Jozef Pavel; Petra Zemankova; Michaela Schneiderova; Lucie Schwarzova; Ivana Ticha; Xiao-Feng Sun; Katerina Jiraskova; Vaclav Liska; Ludmila Vodickova; Pavel Vodicka; Radislav Sedlacek; Zdenek Kleibl; Ragnhild A Lothe; Vladimír Korinek; Libor Macurek
Journal:  Cell Death Dis       Date:  2019-10-28       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.